Novel gene signatures for stage classification of the squamous cell carcinoma of the lung
Abstract The squamous cell carcinoma of the lung (SCLC) is one of the most common types of lung cancer. As GLOBOCAN reported in 2018, lung cancer was the first cause of death and new cases by cancer worldwide. Typically, diagnosis is made in the later stages of the disease with few treatment options...
Main Authors: | Angel Juarez-Flores, Gabriel S. Zamudio, Marco V. José |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-83668-1 |
Similar Items
-
A Novel Pyroptosis-Related Gene Signature for Early-Stage Lung Squamous Cell Carcinoma
by: Li X, et al.
Published: (2021-10-01) -
A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis
by: Tao Fan, et al.
Published: (2021-06-01) -
Identification of seven-gene signature for prediction of lung squamous cell carcinoma
by: Wang Z, et al.
Published: (2019-07-01) -
Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma
by: Jie Zhu, et al.
Published: (2020-01-01) -
Identification of an Immune Gene Expression Signature for Predicting Lung Squamous Cell Carcinoma Prognosis
by: Yubo Yan, et al.
Published: (2020-01-01)